Increased demyelination and axonal damage in metallothionein I+II-deficient mice during experimental autoimmune encephalomyelitis

被引:27
|
作者
Penkowa, M
Espejo, C
Martínez-Caceres, EM
Montalban, X
Hidalgo, J [1 ]
机构
[1] Autonomous Univ Barcelona, Inst Neurosci, E-08193 Barcelona, Spain
[2] Autonomous Univ Barcelona, Dept Cellular Biol Physiol & Immunol, E-08193 Barcelona, Spain
[3] Univ Copenhagen, Panum Inst, Dept Med Anat, DK-2200 Copenhagen, Denmark
[4] Univ Barcelona, Hosp Gen Valle Hebron, Unitat Neuroimmunol Clin, Barcelona 08035, Spain
[5] CTBT, LIRAD, Barcelona, Spain
关键词
metallothionein; EAE/MS; demyelination; neurodegeneration; regeneration; neurotrophic factor;
D O I
10.1007/s000180300013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metallothioneins I+II (MT-I+II) are antioxidant, neuroprotective factors. We previously showed that MT-I+II deficiency during experimental autoimmune encephalomyelitis (EAE) leads to increased disease incidence and clinical symptoms. Moreover, the inflammatory response of macrophages and T cells, oxidative stress, and apoptotic cell death during EAE were increased by MT-I+II deficiency. We now show for the first time that demyelination and axonal damage are significantly increased in MT-I+II deficient mice during EAE. Furthermore, oligodendroglial regeneration, growth cone formation, and tissue repair including expression of trophic factors were significantly reduced in MT-I+II-deficient mice during EAE. Accordingly, MT-I+II have protective and regenerative roles in the brain.
引用
收藏
页码:185 / 197
页数:13
相关论文
共 50 条
  • [1] Increased demyelination and axonal damage in metallothionein I+II-deficient mice during experimental autoimmune encephalomyelitis
    M. Penkowa
    C. Espejo
    E. M. Martínez-Cáceres
    X. Montalban
    J. Hidalgo
    [J]. Cellular and Molecular Life Sciences CMLS, 2003, 60 : 185 - 197
  • [2] Altered inflammatory response and increased neurodegeneration in metallothionein I plus II deficient mice during experimental autoimmune encephalomyelitis
    Penkowa, M
    Espejo, C
    Martínez-Cáceres, EM
    Poulsen, CB
    Montalban, X
    Hidalgo, J
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2001, 119 (02) : 248 - 260
  • [3] Laquinimod reduces inflammation, demyelination and axonal damage in experimental autoimmune encephalomyelitis
    Wegner, C.
    Stadeltmann, C.
    Kaye, J.
    Fine, T.
    Mayk, A.
    Raymond, E.
    Bruck, W.
    [J]. MULTIPLE SCLEROSIS, 2007, 13 : S254 - S254
  • [4] Therapeutic treatment with Laquinimod reduces inflammation, demyelination and axonal damage in experimental autoimmune encephalomyelitis
    Wegner, C.
    Stadelmann, C.
    Brueck, W.
    [J]. ACTA NEUROPATHOLOGICA, 2009, 118 (03) : 464 - 464
  • [5] Reduced inflammation, demyelination and axonal damage after therapeutic laquinimod treatment in experimental autoimmune encephalomyelitis
    Wegner, C.
    Stadelmann, C.
    Brueck, W.
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (09): : S127 - S127
  • [6] Fingolimod protects axonal damage in experimental autoimmune encephalomyelitis
    Jin, Shijie
    Takeuchi, Hideyuki
    Mizuno, Tetsuya
    Suzumura, Akio
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 958 - 958
  • [8] Increased axonal damage in p75NTR-knockout mice after induction of experimental autoimmune encephalomyelitis by adoptive transfer
    Dallenga, T.
    Bittner, A.
    Jaeger, W.
    Vollmar, P.
    Oertel, W. H.
    Sommer, N.
    Moeller, J. C.
    Hemmer, B.
    Stadelmann, C.
    Nessler, S.
    [J]. ACTA NEUROPATHOLOGICA, 2009, 118 (03) : 436 - 436
  • [9] Metallothionein-I overexpression improves experimental autoimmune encephalomyelitis
    Espejo, C
    Hidalgo, J
    Castillo, M
    Penkowa, M
    Montalban, X
    [J]. MULTIPLE SCLEROSIS, 2004, 10 (7032): : S200 - S200
  • [10] Experimental autoimmune encephalomyelitis in histidine decarboxylase deficient mice
    Pedotti, R
    Musio, S
    Scabeni, S
    Gallo, B
    Poliani, PL
    Ohtsu, H
    Mantegazza, R
    [J]. JOURNAL OF NEUROLOGY, 2004, 251 : 51 - 51